SUVEN.NS

Suven Life Sciences Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$11.82B

PE Ratio

-11.459448800495418

EV to Ebitda

-12.639053421694037

Earnings Yield

-721937028.00%

Revenue (TTM)

$1.8M

Net Income (TTM)

$-13.5M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

-32.30%

Profit Margin

0.00%

Return on Equity

—

Debt to Equity Ratio

0.8853882604599769

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$11.82B

Revenue TTM$1.8M

Shares Outstanding218.1M

Float60918753

Insider Ownership72.06%

Institutional Ownership2.51%

Growth Estimates4 fields›

Revenue Growth (Quarterly YoY)-32.30%

EPS Growth (Quarterly YoY)1556.70%

EPS Growth Est Quarterly0

LT EPS Growth Estimates15.40%

Operations14 fields›

Revenue TTM$1.8M

Gross Margin TTM62.39%

Gross Margin (Quarterly)100.00%

Operating Margin TTM-783.23%

Operating Margin (Quarterly)-1773.79%

Profit Margin TTM0.00%

Profit Margin (Quarterly)-1702.48%

Net Income TTM$-13.5M

EPS TTM-9.57

EBIT Margin TTM-759.87%

EBITDA TTM$-14.0M

Capex % of Revenue TTM32.55%

Capital Expenditures$0.60M

FCF % of Revenue (Quarterly)-965.60%

Efficiency1 fields›

ROA-68.17%

Valuation10 fields›

P/E (TTM)-11.459448800495418

P/E Forward0

EV/EBITDA (TTM)-12.639053421694037

EV/Revenues (TTM)81.9189

EV/Revenues Forward87.085424757195

EV/CFO87.085424757195

Price To Book22.609686232566705

Earnings Yield-721937028.00%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity6 fields›

Cash Per Share3.975851441402647

Current Ratio8.00924868004859

Total Assets$1205.80T

Shareholders Equity$564.72T

Debt to Equity0.8853882604599769

Interest Expense$3.3M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield-721937028.00%